Teva Pharma Industries Ltd ADR is a drug manufacturers - specialty & generic business based in the US. Teva Pharma Industries Ltd ADR shares (TEVA) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $33.98 – . Teva Pharma Industries Ltd ADR employs 31,173 staff and has a trailing 12-month revenue of around $17.3 billion.
Become a Finder member, open a SoFi Active Invest account and make a first deposit of $1,000 or more to receive a $150 gift card. Offer ends March 4, 2026.
T&Cs and limits apply.
0588148b-2286-4b8f-9672-9c8cdafc0370-Get up to $1,000 in stock
Get up to $1,000 in stock
Trade stocks, options, ETFs, mutual funds, alternative asset funds
$0 commission on stocks, ETFs and options with no options contract fees
Get up to $1,000 in stock when you open & fund a new Active Invest account.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longerqualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link See full terms and For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
eToro securities trading offered by eToro USA Securities, Inc. (‘the BD”), member of FINRA and SIPC. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finder is not an affiliate and may be compensated if you access certain products or services offered by the BD.
d19c0be9-29b6-4644-a071-32c476ff5e24-Top pick for match bonus
Top pick for match bonus
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $100,000+ to earn a 4% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – TEVA.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Teva Pharma Industries Ltd ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Teva Pharma Industries Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Teva Pharma Industries Ltd ADR price performance over time
Historical closes compared with the close of $33.98 from 2026-02-13
1 week (2026-02-09)
-1.42%
1 month (2026-01-16)
6.99%
3 months (2025-11-14)
33.73%
6 months (2025-08-15)
90.26%
1 year (2025-02-14)
109.11%
2 years (2024-02-16)
160.98%
3 years (2023-02-16)
236.44%
5 years (2021-02-12)
205.58%
Is Teva Pharma Industries Ltd ADR stock undervalued or overvalued?
Valuing Teva Pharma Industries Ltd ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Teva Pharma Industries Ltd ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Teva Pharma Industries Ltd ADR's P/E ratio
Teva Pharma Industries Ltd ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Teva Pharma Industries Ltd ADR shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Teva Pharma Industries Ltd ADR's PEG ratio
Teva Pharma Industries Ltd ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2934. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Teva Pharma Industries Ltd ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Teva Pharma Industries Ltd ADR's EBITDA
Teva Pharma Industries Ltd ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5 billion.
The EBITDA is a measure of a Teva Pharma Industries Ltd ADR's overall financial performance and is widely used to measure a its profitability.
Teva Pharma Industries Ltd ADR financials
Revenue TTM
$17.3 billion
Operating margin TTM
27.28%
Gross profit TTM
$8.9 billion
Return on assets TTM
6.17%
Return on equity TTM
20.79%
Profit margin
8.17%
Book value
$6.88
Market Capitalization
$39.6 billion
TTM: trailing 12 months
Teva Pharma Industries Ltd ADR's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Teva Pharma Industries Ltd ADR.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Teva Pharma Industries Ltd ADR's total ESG risk score
Total ESG risk: 58.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Teva Pharma Industries Ltd ADR's overall score of 58.8 (as at 12/31/2018) is pretty weak – landing it in it in the 76th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Teva Pharma Industries Ltd ADR is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Teva Pharma Industries Ltd ADR's environmental score of 77.02 puts it squarely in the 87th percentile of companies rated in the same sector. This could suggest that Teva Pharma Industries Ltd ADR is a laggard in its sector in terms of its environmental impact, and exposed to a greater level of risk.
Teva Pharma Industries Ltd ADR's social score
Social score: 47.2/100
Teva Pharma Industries Ltd ADR's social score of 47.2 puts it squarely in the 58th percentile of companies rated in the same sector. This could suggest that Teva Pharma Industries Ltd ADR is pretty average in terms of looking after its workforce and social impact.
Teva Pharma Industries Ltd ADR's governance score
Governance score: 65.26/100
Teva Pharma Industries Ltd ADR's governance score puts it squarely in the 81st percentile of companies rated in the same sector. That could suggest that Teva Pharma Industries Ltd ADR is a laggard in its sector in terms of responsible leadership, and exposed to a greater level of risk.
ESG scores also evaluate any incidences of controversy that a company has been involved in. Teva Pharma Industries Ltd ADR scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Teva Pharma Industries Ltd ADR hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Teva Pharma Industries Ltd ADR was last rated for ESG on: 2019-01-01.
Total ESG score
58.8
Total ESG percentile
76.26
Environmental score
77.02
Environmental score percentile
87.16
Social score
47.2
Social score percentile
58.24
Governance score
65.26
Governance score percentile
80.64
Level of controversy
3
Teva Pharma Industries Ltd ADR share dividends
We're not expecting Teva Pharma Industries Ltd ADR to pay a dividend over the next 12 months.
Have Teva Pharma Industries Ltd ADR's shares ever split?
Teva Pharma Industries Ltd ADR's shares were
split on a 2:1 basis on 30 June 2004
. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Teva Pharma Industries Ltd ADR shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Teva Pharma Industries Ltd ADR shares which in turn could have impacted Teva Pharma Industries Ltd ADR's share price.
Over the last 12 months, Teva Pharma Industries Ltd ADR's shares have ranged in value from as little as $12.47 up to $37.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Teva Pharma Industries Ltd ADR's is 0.72. This would suggest that Teva Pharma Industries Ltd ADR's shares are less volatile than average (for this exchange).
Teva Pharma Industries Ltd ADR overview
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders " chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.
Frequently asked questions
null What percentage of Teva Pharma Industries Ltd ADR is owned by insiders or institutions? Currently 0.003% of Teva Pharma Industries Ltd ADR shares are held by insiders and 59.684% by institutions.How many people work for Teva Pharma Industries Ltd ADR? Latest data suggests 31,173 work at Teva Pharma Industries Ltd ADR.When does the fiscal year end for Teva Pharma Industries Ltd ADR? Teva Pharma Industries Ltd ADR's fiscal year ends in December.Where is Teva Pharma Industries Ltd ADR based? Teva Pharma Industries Ltd ADR's address is: 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020What is Teva Pharma Industries Ltd ADR's ISIN number? Teva Pharma Industries Ltd ADR's international securities identification number is: US8816242098What is Teva Pharma Industries Ltd ADR's CUSIP number? Teva Pharma Industries Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 881624209
Discover the best stock picking services based on expert analysis, pricing, and strategy fit. Compare top tools to find the right service for your investing style in 2026.
Discover the best robo-advisors of 2026. Compare fees, account minimums and features from top platforms that automate investing for beginners and pros.
What you need to know about investing in the leading indicator for the overall US stock market.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
